Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Open accessThe DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
The concept of molecular mimicry was established to explain commonalities of structure which developed in response to evolutionary pressures. Most examples of molecular mimicry in medicine have involved homologies of primary protein structure which cause disease. Molecular mimicry can be expanded beyond amino acid sequence to include microRNA and proteomic effects which are either pathogenic or salutogenic (beneficial) in regard to Parkinson's disease, Alzheimer's disease, and related disorders. Viruses of animal or plant origin may mimic nucleotide sequences of microRNAs and influence protein expression. Both Parkinson's and Alzheimer's diseases involve the formation of transmissible self-propagating prion-like proteins. However, the initiating factors responsible for creation of these misfolded nucleating factors are unknown. Amyloid patterns of protein folding are highly conserved through evolution and are widely distributed in the world. Similarities of tertiary protein structure may be involved in the creation of these prion-like agents through molecular mimicry. Cross-seeding of amyloid misfolding, altered proteostasis, and oxidative stress may be induced by amyloid proteins residing in bacteria in our microbiota in the gut and in the diet. Pathways of molecular mimicry induced processes induced by bacterial amyloid in neurodegeneration may involve TLR 2/1, CD14, and NFκB, among others. Furthermore, priming of the innate immune system by the microbiota may enhance the inflammatory response to cerebral amyloids (such as amyloid-β and α-synuclein). This paper describes the specific molecular pathways of these cross-seeding and neuroinflammatory processes. Evolutionary conservation of proteins provides the opportunity for conserved sequences and structures to influence neurological disease through molecular mimicry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Age-related perturbations in the gut microbiome have emerged as crucial factors contributing to age-related pathological conditions, including chronic inflammation,178 neurodegeneration,179 cognitive decline,180 and type 1 and type 2 diabetes.181”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“PD is characterized by accumulation of aggregated and phosphorylated AS in Lewy bodies and Lewy neurites [24] [25] [26].”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“It is estimated that there are 10X more cells and 130X more DNA in the metagenome than in our own bodies [40] [41].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Table 2 Agents inducing molecular mimicry REF Bacteria * [9] [44] [56] Animal viruses * [3] Plant viruses * [4] [5] [15] Amyloids proteins in food [50] [56] Bacteria that make amyloid proteins * * Xanthomonas axonopodis * Exogenous as well as endogenous (found in the microbiota).”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“ApoE, as a lipid-handling gene, influences bile acid secretion in humans and mucin secretion in murine lung, and has immunomodulatory effects [112] [113] [114] [115].”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 2×
“In particular, the importance of diversity of diet leading to diversity of the microbiota is a new concept, which is clinically important [45] [123].”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“The production of anti-inflammatory Treg cells may be enhanced by addition of " rationally selected " Clostridia strains [75].”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“Proteins from gut bacteria may gain access to neurons in the myenteric plexus because of the sampling of gut contents by epithelial microfold (M) cells as well as dendritic cells which deliver antigens to immune cells in Peyer’s patches [58, 59].”
Background
Research works printed but not linked: 1
- [103]103. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39, 51-68.
Cited by
Items 301–338 of 338
Gut Microbiota in Brain diseases
Salami, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00040-1
Microbiome Management of Neurological Disorders
Ortíz, G. G., Bitzer-Quintero, O. K., Niño, C. L. C., Ramírez-Jirano, L. J., González-Usigli, H., Pacheco-Moisés, F. P., Torres-Mendoza, B. M., Mireles-Ramírez, M. A., Hernández-Cruz, J. J., & Delgado-Lara, D. L. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00003-6
Curli-producing E. coli enhances the disease phenotype in an hSOD1 G93A mouse model of ALSPreprint
Kurlawala, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-506373/v1
Interplay between gut bacteria and Parkinson’s disease medication
van Kessel, S. P. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.182831964
Scassellati, C., & Bonvicini, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00103-1
Dementia and Cerebrovascular Disease
Perini, G., Ramusino, M. C., Bernini, S., & Costa, A. C. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_29-1
Mimetismo molecular entre autoproteínas da tireoide e poliproteínas do vírus da hepatite C
Sousa, M. D. A. C., & Andrade, L. J. D. O. (2021) · doi:10.7476/9786586213737.0009
Research Progress of Gut Microbiota’s Function in Neurological and Psychological Diseases
范, 锦. (2023) · Open Journal of Natural Science · doi:10.12677/ojns.2023.113040
Role of Gram-Negative Bacterial Components in Alzheimer’s Disease Pathology
Sawikr, Y., El-Awamie, M. W. M., & Bleiblo, F. A. (2023) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.4.1223.123542
Evangelou, K., Halkas, M., Theodorou, A., Rozani, S., Louka, C., & Angeli, P. (2024) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2024.02.002
Importance of Microbial Diversity on Health
Mukhopadhyay, S., Sunaina, S., Mohanty, T., Das, A., De, A. J., Dwivedi, I., & Aich, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13320-6.00031-7
Microbiota as a ‘black swan’: The extrange case of bacterial amyloids and neurodegeneration
Giraldo, R. (2024) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2024.90.01.04
The Gut Microbiota and NDG: What Is the Interplay
Haiba, S., Idriss, S., & Awad, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_30
AD prevention strategies adapted till present
Naik, R. A., Mir, M. N., Rajpoot, R., Singh, S. R., Singh, K., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00015-x
Friedland, R. P. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197756218.002.0009
Self-citationDo Not Confuse Etiology with Pathophysiology
Friedland, R. P. (2025) · doi:10.1093/med/9780197756218.003.0036
Self-citationUnderstanding Psychoneuroimmunology in Pediatric Development: A Focus on Neurodivergent Populations
Rajan, A. V., & Alexander, A. E. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch006
Microbial Amyloids: Polarisation-Optical Analysis
Emödy, L., & Makovitzky, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-70714-8_6
Cano, J. F., Bernal‐Valencia, M. A., Vargas-Acevedo, P., Mejía‐Salgado, G., Sánchez, A., Correa-Jiménez, Ó., Múnera, M., & de‐la‐Torre, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110321
“However, similarities between the intestinal microbiota and host antigens have been proposed to play a role in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis [14,15].”
«Brain—gut—microbiome» axis in patients with Parkinson’s disease
Жукова, Н. Г., Sayfitdinkhuzhaev, Z. F., Israilova, G. M., Bustonov, O. Y., Nasriddinova, N. A., Gaponova, O. V., Zhukova, I. A., & Masenko, A. Y. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512511218 · Cited by 1
Chen, J., Shi, X., Diao, M., Jin, G., Zhu, Y., Hu, W., & Xi, S. (2020) · Figshare · doi:10.6084/m9.figshare.13059488
THE EFFECT OF MICROBIOTA ON DISEASES
Çakmak, B., & İnkaya, B. V. (2020) · DergiPark (Istanbul University)
The Brain–Gut–Microbiome Axis in Patients with Parkinson’s Disease
Жукова, Н. Г., Sayfitdinkhuzhaev, Z. F., Israilova, G. M., Bustonov, O. Y., Nasriddinova, N. A., Gaponova, O. V., Zhukova, I. A., & Masenko, A. Y. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-01998-x
Peptidoglycan : a key elicitor of the gut- brain axis
Fioriti, F. (2023) · theses.fr (ABES) · doi:10.70675/9e7ce0aaz9b66z467bzbc3fz6fa3bf65d9a6
The ‘gut feeling’: Connecting neurodegenerative diseases and gut microbiota
Niyogi, S., & Basu, S. (2026) · The Microbe · doi:10.1016/j.microb.2026.100719
The Microbiome-Brain Axis in Neurodegenerative Disease: Emerging Insights and Therapeutic Horizons
Prasannakumar, P., Manikandan, S., Ameena, I., & Antony, A. R. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_14
Human microbiomes in neurodegenerative diseases: an overview of their potential involvement
Borrego-Ruiz, A., & Borrego, J. J. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004153
Pathological Remuneration of Oxidative Stress in Limiting Gut-Brain Axis
Kumar, R., Kashyap, A., & Naqvi, S. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_5
Oral microbiota dysbiosis and the oral-X axis in chronic diseases
Li, E., Huang, J., Yao, J., Lei, M., & Wu, M. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102274 · Cited by 1
Role of incretins in Alzheimer’s disease and their impact on behavioral aspects
Yang, J., Mao, T., & Gao, L. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004195
Sattar, Z., & Asili, J. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11152-1
Song, D. H., Lee, Y.-R., Yu, S. M., & An, J. H. (2026) · Food & Function · doi:10.1039/d6fo02214f
Zebrafish as a translational model for peptide-mediated synaptic dysfunction related to obesity
Rodrigues, A. C., Lacerda, A. P., Mukoyama, L. T. H., de Carvalho, G. B., da Mata, J. A. L., Buccini, D. F., Franco, O. L., & Migliolo, L. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1845252
“Molecular mimicry involves bacterial amyloids, such as the Curli protein from Escherichia coli , which are structurally analogous to human A β and α -synuclein and can trigger exaggerated immune responses, accelerating protein aggregation linked to neurodegeneration (Friedland, 2015).”
Jalal, M. E., Hamidi, R., Harris, B., Elmaghraby, A. S., Friedland, R. P., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261478312
“Functional bacterial amyloid proteins produced by scalp microbes may in fl uence protein misfolding and in fl ammatory processes 35 – 37 .”
Self-citationXu, B., Li, X., Dong, S., Zhang, Z., Jin, D., Li, G., & Wang, J. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71117
“Research indicates that diet and specific nutrients can influence the composition of the gut microbial community [12] and amyloid production or aggregation [13, 14].”
Bowler, B., Nasir, A. R., Szewczyk, A., Ocañas, S. R., Unnikrishnan, A., & Nouh, C. D. (2026) · Pathophysiology · doi:10.3390/pathophysiology33040074
“This priming effect on the immune system may lead to an enhanced response to CNS amyloid and microglia dysregulation [159,166].”
Sharma, R., Kumar, G., & Thakur, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02433-w
Metadata
- Authors
- Friedland, R. P.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Friedland, Robert P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2015-03-18
- Volume
- 45
- Issue
- 2
- Pages
- 349-362
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1526611045
- Cited by
- 338
- References
- 129
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 31 · 2023: 30 · 2022: 52 · 2021: 49 · 2020: 35 · 2019: 25 · 2018: 24 · 2017: 24 · 2016: 13 · 2015: 10
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- molecular mimicry, gut microbiota
- MeSH terms
- Animals, Humans, Cytokines, Molecular Mimicry, Neurodegenerative Diseases, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.